Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

Journal of Clinical Oncology, Vol 23, No 28 (October 1), 2005: pp. 6949-6956
© 2005 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2005.12.514

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Brundage, M.
Right arrow Articles by Pater, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Brundage, M.
Right arrow Articles by Pater, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Communicating Quality of Life Information to Cancer Patients: A Study of Six Presentation Formats

M. Brundage, D. Feldman-Stewart, A. Leis, A. Bezjak, L. Degner, K. Velji, L. Zetes-Zanatta, D. Tu, P. Ritvo, J. Pater

From the Radiation Oncology Research Unit, Queen's University, Kingston; University of Toronto; Princess Margaret Hospital, Toronto, Ontario; Department of Community Health & Epidemiology, University of Saskatchewan, Saskatoon, Saskatchewan; Faculty of Nursing, University of Manitoba, Winnipeg, Manitoba, Canada; and the National Cancer Institute of Canada Clinical Trials Group

Address reprint requests to M.D. Brundage, MD, Division of Cancer Control and Epidemiology, Queen's Cancer Research Institute, Queen's University, Kingston, Ontario, Canada, K7L 3N6; e-mail: michael.brundage{at}krcc.on.ca

PURPOSE: To determine which formats for presenting health-related quality of life (HRQL) data are interpreted most accurately and are most preferred by cancer patients. Patients often want a great deal of information about cancer treatments, including information relevant to HRQL. Clinical trials provide methodologically sound HRQL data that may be useful to patients.

PATIENTS AND METHODS: In a multicenter study, 198 patients with previously treated cancer participated in a structured interview. Participants judged HRQL information presented in one textual and five graphical formats. Outcome measures included the accuracy of patients' interpretations and ease-of-use and helpfulness ratings for each format.

RESULTS: Correct interpretations ranged from 85% to 98% across formats (F = 10.3, P < .0001) with line graphs of mean HRQL scores over time being interpreted correctly most often. Older patients and less-educated patients were less likely to interpret graphs accurately (F = 7.3, P = .008; and F = 10.6, P = .001, respectively), but all groups were most accurate on simple line graphs. Multivariate analysis revealed that format type, participant age and education were independent predictors of accuracy rates. Patients' ratings also varied across formats both for ease of understanding scores (F = 12.1, P < .0001) and for helpfulness scores (F = 13.2, P < .0001), with line graphs being rated highest on both outcomes.

CONCLUSION: Patients generally prefer a simple linear representation of group mean HRQL scores, and can accurately interpret data presented in this format more than 98% of the time irrespective of their age group and educational level. The findings have important implications for the communication of clinical trial HRQL results.

Supported by an operating grant from the National Cancer Institute of Canada. The funding agreement ensured the authors' independence in designing the study, interpreting the data, writing and publishing the report.

Presented at the 39th annual meeting of the American Society of Clinical Oncology, Chicago, IL, May 31-June 3, 2003.

Authors' disclosures of potential conflicts of interest are found at the end of this article.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
JCOHome page
A. Bezjak, C. W. Lee, K. Ding, M. Brundage, T. Winton, B. Graham, M. Whitehead, D. H. Johnson, R. B. Livingston, L. Seymour, et al.
Quality-of-Life Outcomes for Adjuvant Chemotherapy in Early-Stage Non-Small-Cell Lung Cancer: Results From a Randomized Trial, JBR.10
J. Clin. Oncol., November 1, 2008; 26(31): 5052 - 5059.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
M. Brundage, D. Osoba, A. Bezjak, D. Tu, M. Palmer, and J. Pater
Lessons Learned in the Assessment of Health-Related Quality of Life: Selected Examples From the National Cancer Institute of Canada Clinical Trials Group
J. Clin. Oncol., November 10, 2007; 25(32): 5078 - 5081.
[Abstract] [Full Text] [PDF]


Home page
Mayo Clin Proc.Home page
M. H. Frost, A. E. Bonomi, J. C. Cappelleri, H. J. Schunemann, T. J. Moynihan, N. K. Aaronson, and Clinical Significance Consensus Meeting Group
Applying Quality-of-Life Data Formally and Systematically Into Clinical Practice
Mayo Clin. Proc., October 1, 2007; 82(10): 1214 - 1228.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2005 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online